Table: begin end state 1 57 cytoplasmic 58 79 transmembrane 80 87 non-cytoplasmic 88 108 transmembrane 109 122 cytoplasmic 123 142 transmembrane 143 147 non-cytoplasmic 148 170 transmembrane 171 181 cytoplasmic 182 205 transmembrane 206 216 non-cytoplasmic 217 237 transmembrane 238 284 cytoplasmic 285 306 transmembrane 307 322 non-cytoplasmic 323 343 transmembrane 344 350 cytoplasmic 351 367 transmembrane 368 372 non-cytoplasmic 373 394 transmembrane 395 404 cytoplasmic 405 428 transmembrane 429 439 non-cytoplasmic 440 459 transmembrane 460 480 cytoplasmic
Input: >Pf6N2E2_2115 LSSKKFKLYDVYQHRHLHDAPHKNNEWEKNQVNTSSLKANAGADPVLLSAIAKVKRHILP LFVIMFIVNYIDRVNIGFVRAHMEHDLGIGAAAYGLGAGLFFVGYALFEVPSNILLQRIG ARIWLTRIMLTWGLVAAAMAFIQNETHFYILRFLLGVAEAGFFPGVIYYFTRWLPGVERG KAIAIFLSGSAIASLISGPLSGLLLQINGLGMHGWQWMYFIEGMFSVCLCVFVWFWLDSK PHDAKWLSREEQDVLVKTIDDEQRAREAASPIKLSIGQLLKDRQIILFCLIYFFIQLTIY AATFWLPSIIKKMGELSDIQVGMFNSIPWLLSIVGMYAFASLSAKWKFQQAWVATALLIA AAGMFMSTTGGPIFAFVAICFAALGFKSASSLFWPIPQAYLDARIAAGVIALINSVGNLG GFVAPTTFGLLEEHTGSIQGGLYGLAATSIIAAIIVFAARNTPKPKSATTPANPPAASHV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server